Evidence map›Paper›PMID 26735329›Full record

ArticleJournal of affective disorders2016

Lipid peroxidation biomarkers in adolescents with or at high-risk for bipolar disorder.

Gustavo Scola, Robert K McNamara, Paul E Croarkin, Jarrod M Leffler, Kathryn R Cullen, Jennifer R Geske, Joanna M Biernacka, Mark A Frye, Melissa P DelBello, Ana C Andreazza

Open access · greenAbstract read
In one paragraph

Article in Journal of affective disorders, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Biomarkers of bipolar disorder in omics and neuroimaging.Journal of pharmaceutical analysis · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Superoxide dismutase and neurological disorders.IBRO neuroscience reports · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Gustavo ScolaDepartment of Psychiatry and Pharmacology and Toxicology, University of Toronto & Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Robert K McNamaraDepartment of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Paul E CroarkinDepartment of Psychiatry and Psychology, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Jarrod M LefflerDepartment of Psychiatry and Psychology, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Kathryn R CullenDepartment of Psychiatry, University of Minnesota, Minneapolis, MN, USA.
Jennifer R GeskeDepartment of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Joanna M BiernackaDepartment of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Mark A FryeDepartment of Psychiatry and Psychology, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Melissa P DelBelloDepartment of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Ana C AndreazzaDepartment of Psychiatry and Pharmacology and Toxicology, University of Toronto & Centre for Addiction and Mental Health, Toronto, Ontario, Canada. Electronic address: ana.andreazza@utoronto.ca.
Mayo Clinic · USCentre for Addiction and Mental Health · CAMayo Clinic in Florida · USUniversity of Cincinnati Medical Center · USUniversity of Minnesota · US

Funding

LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., KISSELA, BRETT M · 2015 to 2024
$37.5M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
Multimodal Neuroimaging of Treatment Effects in Adolescent ManiaR01MH080973 · NIMH · UNIVERSITY OF CINCINNATI · PI DELBELLO, MELISSA P · 2009 to 2013
$3.5M
The Mayo Clinic Center for Individualized Treatment of Alcohol DependenceP20AA017830 · NIAAA · MAYO CLINIC ROCHESTER · PI CHOI, DOO-SUP · 2009 to 2010
$2.5M
1H-MR Spectroscopy of Bipolar Depression Before and After Lamotrigine TreatmentR01MH079261 · NIMH · MAYO CLINIC ROCHESTER · PI FRYE, MARK A · 2009 to 2013
$1.2M
Glutamate Probes in Adolescent DepressionK23MH100266 · NIMH · MAYO CLINIC ROCHESTER · PI CROARKIN, PAUL E · 2014 to 2017
$685k
Canadian Institutes of Health Research MOP-133439NCATS NIH HHS UL1 TR000114NCATS NIH HHS UL1 TR001425NIAAA NIH HHS P20 AA017830NIMH NIH HHS K23 MH100266NIMH NIH HHS K23MH100266NIMH NIH HHS R01 MH079261NIMH NIH HHS R01 MH080973NIMH NIH HHS R34 MH081206
6 · The paper itself

Abstract

backgroundPrior work suggests that adult bipolar disorder (BD) is associated with increased oxidative stress and inflammation. This exploratory study examined markers of lipid and protein oxidation and inflammation in adolescents with and at varying risk for BD type I (BD-I).

methodsBlood was obtained from four groups of adolescents (9-20 years of age): (1) healthy comparison subjects with no personal or family history of psychiatric disorders (n=13), (2) subjects with no psychiatric diagnosis and at least one parent with BD-I ('high-risk', n=15), (3) subjects with at least one parent with BD-I and a diagnosis of depressive disorder not-otherwise-specified ('ultra-high-risk', n=20), and (4) first-episode patients exhibiting mixed or manic symptoms that received a diagnosis of BD-I (n=16). Plasma levels of lipid peroxidation (LPH, 4-HNE, 8-ISO), protein carbonyl, and inflammation (IL-1α-β, IL-6, IL-10, IFNγ, TNFα) were assessed using analysis of variance and covariance models.

resultsLPH was lower in adolescents with fully syndromal BD than controls, while LPH levels in the at-risk groups were between healthy controls and fully syndromal BD. Post-hoc analysis showed a non-significant increase in the (4-HNE+8-ISO)/LPH ratio suggesting a potential conversion of LPH into late-stage markers of lipid peroxidation. There were no significant differences among protein carbonyl content and inflammatory markers.

conclusionsIn adolescents, fully syndromal BD is associated with significant reductions in LPH levels, and LPH levels decrease along the spectrum of risk for BD-I. Quantifying lipid peroxidation in longitudinal studies may help clarify the role of LPH in BD risk progression.

Indexed as

Lipid PeroxidationAdolescentAdultAldehydesBiomarkersBipolar DisorderCase-Control StudiesDinoprostFemaleHumansInterleukin-1Interleukin-10Interleukin-6InterleukinsLipid PeroxidesMale4-hydroxy-2-nonenal8-epi-prostaglandin F2alphaAldehydesBiomarkersDinoprostIL10 protein, humanInterleukin-1Interleukin-10Interleukin-6InterleukinsLipid PeroxidesTumor Necrosis Factor-alphaAdolescent bipolar disorderAt-risk adolescentsLipid peroxidationOxidative stress markers

Identifiers

PMID26735329
PMCPMC5549852
OpenAlexW2218287850

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.